Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Abiomed Inc.

Clinicaltrial registered17 Nov 2026

Abiomed Inc.

17 Nov 2026: Trial registered · Left Ventricular Impella Device Real-World Evaluation in Pediatric Patients. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
17 Nov 2026
Title
Left Ventricular Impella Device Real-World Evaluation in Pediatric Patients
Conditions
Cardiogenic Shock, Heart Failure, Acute Decompensated Heart Failure (ADHF), Cardiomyopathy
Study Type
Observational
Status
Active Not Recruiting
Countries
United States
Country
United States
Reference
NCT07943182
Location
United States
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Abiomed Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for Abiomed Inc. in our registers.

More from United States

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.